関連する実験動画
Updated: Aug 17, 2025

07:20
Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein
Published on: June 16, 2023
2.2K
ATG9Aは,非伝統的なリソソーム標的経路によってTNF細胞毒性を防止する
Jon Huyghe1,2, Dario Priem1,2, Lisette Van Hove1,2
1VIB Center for Inflammation Research, 9052 Ghent, Belgium.
まとめ
腫瘍死滅因子 (TNF) は細胞死を引き起こすが,ATG9AとFIP200を含む新しいチェックポイントは,細胞毒性複合体を分解することによってこれを防ぐ. このメカニズムは,TNF受容体1 (TNFR1) 媒介の胚死亡と皮膚炎から保護します.
科学分野:
- 免疫学
- 細胞生物学
- 分子生物学
背景:
- 腫瘍死因 (TNF) は免疫において二重の役割を果たし,感染反応を助長するが,また炎症性疾患を引き起こす.
- 細胞死チェックポイントは通常,有害な効果を防ぐためにTNF誘発の細胞毒性を抑制します.
- これらのチェックポイントの不活性化により,TNFは細胞死を誘発します.
研究 の 目的:
- TNF誘発アポトーシスを調節する新しい細胞死チェックポイントを特定し,特徴づけること.
- このチェックポイントが細胞毒性を防ぐ分子メカニズムを明らかにする.
- このチェックポイントの生理学的関連性を in vivo で調べる.
主な方法:
- TNF誘発細胞死経路と複合体の形成を調査した.
- 細胞とマウスのモデルでオートファギー関連9A (ATG9A) とFIP200を活用した.
- LC3 独立したメカニズムを含む,リソソムの標的と分解経路を調べた.
- TNFR1媒介の胎児死亡率と皮膚炎における特定されたチェックポイントの役割を評価した.
主要な成果:
- TNF検出時に形成される細胞毒性複合体IIaを排毒することでアポトーシスを防ぐチェックポイントについて説明しました.
- ATG9AとFIP200はLC3独立の溶解体経路によって複合体IIaの分解を促進することが示された.
- この解毒メカニズムはTNFR1媒介の胚死亡をマウスで抑制することが示された.
- マウスモデルでの炎症性皮膚疾患に対する保護作用が確認された.
結論:
- ATG9AとFIP200を含む新しい細胞死チェックポイントは,複合体IIaのリソソーム分解によってTNF誘発のアポトーシスを調節する.
- このメカニズムは,有害な炎症反応とTNFによって媒介される胚死亡を防ぐために不可欠です.
- この経路を理解することで TNFによって引き起こされる病状の制御に 洞察を得ることができます
関連する概念動画
Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
The Extrinsic Apoptotic Pathway
6.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
210
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
210

